Intas Pharmaceuticals
Dilip Chandak currently serves as the General Manager for the Quality Control function at Intas Pharmaceuticals since September 2024. Prior to joining Intas Pharmaceuticals, Dilip Chandak held the position of General Manager for Quality Control at CRONUS PHARMA LLC from June 2022 to September 2024. Dilip Chandak's extensive experience in the pharmaceutical industry includes a long tenure at Lupin, where the role of Deputy General Manager (DGM) was held from July 2010 to September 2022.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.